Form 8-K BioTelemetry, Inc. For: Jul 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
BioTelemetry's (BEAT) Mednet Served with Subpoena in New Jersey
August 1, 2014 12:49 PM EDTBioTelemetry (NASDAQ: BEAT) disclosed the following with its 10-Q, which was filed Friday morning [emphasis ours]:
As part of our business operations, we submit claims on behalf of patients directly to, and receive payments from, Medicare, Medicaid, and other third-party payors. We are subject to extensive government regulation, including requirements for submitting reimbursement claims under appropriate codes and maintaining certain documentation to support our... More
BioTelemetry (BEAT) Tops Q1 EPS by 1c
July 31, 2014 4:57 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $40.95 million.
For earnings history and earnings-related data on BioTelemetry (BEAT) click here.
... More